Valley National Advisers Inc. decreased its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,241 shares of the company’s stock after selling 174 shares during the period. Valley National Advisers Inc.’s holdings in Colgate-Palmolive were worth $111,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in CL. Union Savings Bank lifted its stake in Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after acquiring an additional 134 shares in the last quarter. Avion Wealth boosted its holdings in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter worth about $32,000. Core Wealth Advisors Inc. increased its stake in Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares during the last quarter. Finally, McGlone Suttner Wealth Management Inc. purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $34,000. 80.41% of the stock is owned by institutional investors.
Colgate-Palmolive Price Performance
NYSE CL traded down $0.23 on Wednesday, hitting $95.89. The stock had a trading volume of 2,114,411 shares, compared to its average volume of 4,483,130. The firm has a 50-day moving average of $94.17 and a 200-day moving average of $87.90. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $99.08. The company has a market capitalization of $78.67 billion, a price-to-earnings ratio of 30.34, a price-to-earnings-growth ratio of 3.57 and a beta of 0.39.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.
Insider Activity at Colgate-Palmolive
In other news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the stock. Citigroup raised their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Bank of America upped their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Argus raised their target price on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Finally, Morgan Stanley upped their price target on Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a research report on Tuesday, May 28th. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $93.83.
Read Our Latest Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- How to Invest in the Best Canadian Stocks
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What is the FTSE 100 index?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Using the MarketBeat Dividend Yield Calculator
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.